Product Images Rezvoglar Kwikpen
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Rezvoglar Kwikpen NDC 0002-8980 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
REZVOGLAR™ KwikPen® is a prefilled insulin delivery device for subcutaneous use only. It contains insulin glargine-aglr injection with 100 units per mL. The device can inject from 1 to 80 units in a single injection. Each 5x3mL pen is recommended for single patient use only and should be used cautiously under medical supervision. The device should be stored refrigerated between 36°F to 46°F (2°C to 6°C) and should not be frozen. After opening, the device should be stored at room temperature up to 86°F (30°C) and protected from heat and light. The device should be discarded after 28 days of opening. The device is manufactured by El Lilly and Company and for information, call 1-800-545-5970.*
This is a list of parts related to KwikPen, a type of insulin pen. The parts include the pen cap, cartridge holder, label, dose indicator, cap clip, rubber seal, plunger, pen body, dose window, and knob. These parts are essential to the functioning of the insulin pen.*
This appears to be a partial product label for a pen needle assembly. The label indicates that the product includes the dose knob and outer needle shield, but does not include the needles themselves. There is also a green ring and paper tab mentioned. Unfortunately, without more context it is difficult to determine the size or type of pen needle.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.